News Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Email Alerts Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 Keywords Go Advanced Search Keywords Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Mar 28, 2013 ARIKACE Receives Orphan Drug Designation for Treating Infections Caused by Non-Tuberculous Mycobacteria Mar 27, 2013 Insmed to Present at Future Leaders in the Biotech Industry Conference Mar 18, 2013 Insmed Reports Fourth Quarter and Full Year 2012 Financial Results Mar 11, 2013 Insmed to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013 Feb 26, 2013 Insmed to Present at Two Upcoming Investor Conferences Feb 6, 2013 Insmed to Present at Two Upcoming Healthcare Investor Conferences Dec 13, 2012 Insmed to Present at 31st Annual J.P. Morgan Healthcare Conference Nov 13, 2012 Insmed Announces CLEAR-108 Phase 3 Clinical Study of ARIKACE® in Cystic Fibrosis Patients with Pseudomonas Lung Infections Has Completed Target Enrollment Nov 12, 2012 Insmed To Present At Two Upcoming Investor Conferences Nov 7, 2012 Insmed Appoints 15-Year Life Sciences Industry Veteran Andrew Drechsler as Chief Financial Officer Nov 7, 2012 Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2012 Oct 24, 2012 Insmed to Host 2012 Third Quarter Earnings Conference Call Sep 28, 2012 Insmed Announces Pricing of Approximately $26 Million Direct Public Offering Aug 30, 2012 Insmed to Present at Stifel Nicolaus 2012 Healthcare Conference Aug 14, 2012 Insmed to Present at 2012 Wedbush PacGrow Life Sciences Management Access Conference Aug 7, 2012 Insmed Announces Financial Results For Second Quarter And Six-months Ended June 30, 2012 Aug 6, 2012 Pharmaceutical Industry Veteran Al Altomari Elected To Insmed's Board Of Directors Aug 2, 2012 Insmed Receives Second Composition Of Matter Patent For ARIKACE® Jul 30, 2012 Insmed Announces Planned Departure Of Chief Financial Officer Jul 24, 2012 Insmed to Host 2012 Second Quarter Earnings Conference Call Jul 10, 2012 Insmed To Present At JMP Securities 7th Annual Healthcare Conference Jul 2, 2012 Insmed Secures $20 Million Loan Agreement With Hercules Technology Growth Capital Jun 27, 2012 Insmed Announces First Patient Dosed in TARGET-NTM Phase 2 Clinical Trial of ARIKACE® in Patients with Non-Tuberculous Mycobacteria (NTM) Lung Disease May 30, 2012 Insmed Provides Corporate Update May 23, 2012 Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease Show 5102550100 per page«1…12131415161718…28» Stay In The Loop Want to stay up to date on our news, events, and filings? Set up your email alerts. Sign Up View the latest Insmed Investor Presentation Download